These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Heparin locks: their advantages and disadvantages. Thomas RB; Salter FJ Hosp Formul; 1975 Nov; 10(11):536-8. PubMed ID: 10237817 [No Abstract] [Full Text] [Related]
3. The plastic heparin lock. Scheidt WE Am J Surg; 1974 Jul; 128(1):118. PubMed ID: 4834905 [No Abstract] [Full Text] [Related]
4. Intermittant i.v. therapy without heparin: a study. Harrigan CA NITA; 1985; 8(6):519-20. PubMed ID: 3852096 [No Abstract] [Full Text] [Related]
5. A comparison of the rate of complications with heparin-lock and keep-open I.V.'s. Hanson RL Commun Nurs Res; 1977 Mar; 8():188-200. PubMed ID: 585595 [No Abstract] [Full Text] [Related]
7. In vitro contamination of "piggyback/heparin lock" assemblies: prevention of contamination with a closed, positive locking device (Click-Lock). Gibilisco PA; Lopez GA; Appleman MD; Millburg WJ; Kushell DL; Elowitz L; Johnson PA; Zenowich D JPEN J Parenter Enteral Nutr; 1986; 10(4):431-4. PubMed ID: 3747096 [TBL] [Abstract][Full Text] [Related]
8. Continuous long term heparin therapy--dosage problems using an Infusaid device. Späth G; Helber MU; Eisele R Life Support Syst; 1985; 3(1):57-9. PubMed ID: 3990349 [No Abstract] [Full Text] [Related]
9. Heparin and polychemotherapy for treatment of lung cancer. Rohwedder JJ; Sagastume E Cancer Treat Rep; 1977 Oct; 61(7):1399-401. PubMed ID: 589603 [No Abstract] [Full Text] [Related]
10. Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group. Bodey GP; Coltman CA; Hewlett JS; Freireich EJ Arch Intern Med; 1976 Dec; 136(12):1383-8. PubMed ID: 1069570 [No Abstract] [Full Text] [Related]
12. Nursing care for the patient with an Ommaya reservoir. Esparza DM; Weyland JB Oncol Nurs Forum; 1982; 9(4):17-20. PubMed ID: 6923413 [No Abstract] [Full Text] [Related]
13. [Use of continuous flow heparin in resuscitation]. Scalet M; Cornu P Anesth Analg (Paris); 1977; 34(6):1239-41. PubMed ID: 350091 [No Abstract] [Full Text] [Related]
14. Potential life-threatening variations of drug concentrations in intravenous infusion systems: potassium chloride, insulin, and heparin. Bergman N; Vellar ID Med J Aust; 1982 Sep; 2(6):270-2. PubMed ID: 6755202 [TBL] [Abstract][Full Text] [Related]
15. [The role of cytarabine in polychemotherapy of leukemia]. Quaglino D; De Pasquale A; Zanni G Haematologica; 1972; 57(7):371-88. PubMed ID: 4628584 [No Abstract] [Full Text] [Related]
16. Treatment of feline myelogenous leukemia: four case reports. Henness AM; Crow SE J Am Vet Med Assoc; 1977 Aug; 171(3):263-6. PubMed ID: 268327 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of thrombophlebitis of the extremities by paravasal and intraspongiosa infusions of a thrombolytic mixture]. Askerkhanov RP; Zakariev ZM Vestn Khir Im I I Grek; 1982 Oct; 129(10):55-9. PubMed ID: 7179665 [No Abstract] [Full Text] [Related]
19. [A common therapy program of leukemia for several hospitals]. Gahrton G Nord Med; 1970 Dec; 84(49):1574. PubMed ID: 5488587 [No Abstract] [Full Text] [Related]
20. [Treatment of acute leukemia]. Barry A; Delage JM Union Med Can; 1970 Jun; 99(6):1045-54. PubMed ID: 5280031 [No Abstract] [Full Text] [Related] [Next] [New Search]